Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 8/20 | 0.46 |
| ▸ | RECQL | P46063 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | BLM | P54132 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.46 |
| ▸ | SMAD3 | P84022 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23860297 | 0.88 | RECQL (0.57) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL23860298 | 0.88 | HPGD (0.46) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL486832 | 0.86 | HPGD (0.64) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL1263259 | 0.85 | HPGD (0.63) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL4304748 | 0.85 | HPGD (0.63) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL6389146 | 0.82 | HPGD (0.54) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL15106845 | 0.81 | HPGD (0.48) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL11206362 | 0.81 | HPGD (0.52) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL7454803 | 0.79 | ALDH1A1 (0.50) | HPGDALOX12ALDH1A1BRCA1HSD17B10 | |
| SCHEMBL16432229 | 0.76 | HPGD (0.58) | HPGDALOX12ALDH1A1BRCA1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753467-A4 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS INC (US) | 2008-09-17 | — | — | EP | claimed |
| EP-1753467-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | Xantech Pharmaceuticals, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| WO-2006001925-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS, INC. (US) | 2006-01-05 | — | — | WO | claimed |
| EP-1753467-A4 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS INC (US) | 2008-09-17 | — | — | EP | disclosed |
| EP-1753467-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | Xantech Pharmaceuticals, Inc. (US) | 2007-02-21 | — | — | EP | disclosed |
| WO-2006001925-A1 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING RADIOLABELED HALOGENATED XANTHENES AND METHODS FOR POSITRON EMISSION IMAGING WITH RADIOLABELED HALOGENATED XANTHENE DIAGNOSTIC AGENTS | XANTECH PHARMACEUTICALS, INC. (US) | 2006-01-05 | — | — | WO | disclosed |
| EP-1578454-A1 | ULTRASOUND CONTRAST USING HALOGENATED XANTHENES | Xantech Pharmaceuticals, Inc. (US) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004052407-A1 | ULTRASOUND CONTRAST USING HALOGENATED XANTHENES | XANTECH PHARMACEUTICALS, INC. (US) | 2004-06-24 | — | — | WO | disclosed |